Spots Global Cancer Trial Database for bexarotene
Every month we try and update this database with for bexarotene cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | NCT00514293 | Lung Cancer | bexarotene capecitabine carboplatin cisplatin docetaxel tretinoin | 18 Years - | National Cancer Institute (NCI) | |
| Bexarotene in Preventing Breast Cancer in Women at Genetic Risk | NCT00055991 | Breast Cancer | bexarotene | 18 Years - | Baylor Breast Care Center | |
| A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides | NCT05296304 | Cutaneous T-cel... | Bexarotene Total Skin Elec... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer | NCT03323658 | Breast Atypical... Breast Atypical... Breast Ductal C... Breast Lobular ... Invasive Breast... | Bexarotene Questionnaire A... | 18 Years - | National Cancer Institute (NCI) | |
| Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | NCT00514293 | Lung Cancer | bexarotene capecitabine carboplatin cisplatin docetaxel tretinoin | 18 Years - | National Cancer Institute (NCI) | |
| A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study) | NCT01578499 | Primary Cutaneo... Mycosis Fungoid... Cutaneous T-Cel... | Brentuximab Ved... Methotrexate Bexarotene | 18 Years - | Takeda | |
| Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer | NCT00050960 | Non-small Cell ... | bexarotene with... carboplatin and... | - | Eisai Inc. | |
| BATTLE Program: Tarceva and Targretin in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | NCT00411632 | Lung Cancer | Bexarotene Erlotinib | 18 Years - | M.D. Anderson Cancer Center | |
| A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung Cancer | NCT00238628 | Lung Cancer | Bexarotene Iressa | 18 Years - | Stanford University | |
| The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC | NCT04664829 | Metastatic Trip... | Bexarotene Capecitabine | 21 Years - | National Cancer Centre, Singapore | |
| Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer | NCT03323658 | Breast Atypical... Breast Atypical... Breast Ductal C... Breast Lobular ... Invasive Breast... | Bexarotene Questionnaire A... | 18 Years - | National Cancer Institute (NCI) | |
| A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression | NCT00718770 | Thyroid Cancer | Bexarotene | 18 Years - | University of Colorado, Denver | |
| Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL | NCT00178841 | Cutaneous T-cel... Mycosis Fungoid... Sezary Syndrome | Rosiglitazone a... | 18 Years - | Vanderbilt University | |
| The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC | NCT04664829 | Metastatic Trip... | Bexarotene Capecitabine | 21 Years - | National Cancer Centre, Singapore | |
| Intravenous (IV) Decitabine and Oral Bexarotene for Acute Myelogenous Leukemia (AML) | NCT01001143 | Leukemia, Myelo... | Decitabine Bexarotene | 18 Years - | Washington University School of Medicine | |
| A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study) | NCT01578499 | Primary Cutaneo... Mycosis Fungoid... Cutaneous T-Cel... | Brentuximab Ved... Methotrexate Bexarotene | 18 Years - | Takeda | |
| Study of Bexarotene in Patients With Acute Myeloid Leukemia | NCT00316030 | AML Acute Myeloid L... | Bexarotene | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC | NCT04664829 | Metastatic Trip... | Bexarotene Capecitabine | 21 Years - | National Cancer Centre, Singapore | |
| Bexarotene and Interferon Alfa in Treating Patients With Cutaneous T-Cell Lymphoma | NCT00030849 | Lymphoma | recombinant int... bexarotene | 18 Years - | National Cancer Institute (NCI) | |
| Bexarotene and Interferon Alfa in Treating Patients With Cutaneous T-Cell Lymphoma | NCT00030849 | Lymphoma | recombinant int... bexarotene | 18 Years - | National Cancer Institute (NCI) | |
| A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides | NCT05296304 | Cutaneous T-cel... | Bexarotene Total Skin Elec... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL) | NCT01007448 | Refractory Cuta... | Bexarotene | 18 Years - | Bausch Health Americas, Inc. | |
| Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer | NCT00050973 | Non-small Cell ... | bexarotene | - | Eisai Inc. | |
| A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides | NCT05296304 | Cutaneous T-cel... | Bexarotene Total Skin Elec... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Phase II Study of Bexarotene in Patients With Acute Myeloid Leukemia | NCT00615784 | Acute Myeloid L... | Bexarotene | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Preoperative Bexarotene Treatment for Cushing's Disease | NCT00845351 | Cushing's Disea... | Bexarotene | 18 Years - 65 Years | University of Virginia | |
| Intravenous (IV) Decitabine and Oral Bexarotene for Acute Myelogenous Leukemia (AML) | NCT01001143 | Leukemia, Myelo... | Decitabine Bexarotene | 18 Years - | Washington University School of Medicine |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
